Patent Assignment
Reel/Frame 053389/0100
Change of Name
Recorded: 2020-08-03
Pages: 6
Assignor
REGENACY PHARMACEUTICALS, LLC
Executed: 2020-03-20
Assignee
REGENACY PHARMACEUTICALS, INC.
303 WYMAN STREET, SUITE 300, BOSTON, MASSACHUSETTS, 02451
Covered Property
(1)
Substituted Piperazines as Selective HDAC1,2 Inhibitors
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.